Paul Marzenell

4-Azidobenzyl ferrocenylcarbamate as an anticancer prodrug activated under reductive conditions.

A. Mokhir, Jevgenij A. Raskatov, K. Meyer, 2016, Journal of inorganic biochemistry.

Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cells.

H. Erfle, A. Mokhir, Paul Marzenell, 2014, Bioorganic & medicinal chemistry letters.

Aminoferrocene-based prodrugs activated by reactive oxygen species.

F. Wenz, A. Mokhir, E. Jentzsch, 2012, Journal of medicinal chemistry.

Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells.

L. Sellner, T. Zenz, V. Pavlov, 2013, Journal of medicinal chemistry.

Short, terminally modified 2'-OMe RNAs as inhibitors of microRNA.

H. Erfle, V. Starkuviene, A. Mokhir, 2013, Chemical communications.